High-performance liquid chromatographic assay for vigabatrin and its primary degradation product in a pharmaceutical tablet formulation.
Chen
T M
TM
Merrell Dow Research Institute, Cincinnati, OH 45215.
Contario
J J
JJ
Fike
R R
RR
D000614:Aminocaproates / Q000032:analysis*; D000927:Anticonvulsants / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D013607:Tablets; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D013607:Tablets; D020888:Vigabatrin